Literature DB >> 14533784

Resetting the problem of cell death following muscle-derived cell transplantation: detection, dynamics and mechanisms.

Daniel Skuk1, Nicolas J Caron, Marlyne Goulet, Brigitte Roy, Jacques P Tremblay.   

Abstract

We conducted a study in mice to reevaluate and clarify many aspects of the early survival of muscle cells following transplantation. Male mouse muscle cells (primary-cultures and T-antigen-immortalized clones) labeled with [14C]thymidine and beta-galactosidase were injected into female muscles. Each label was detected in the muscles after different time periods. TUNEL, alizarin red, and immunodetection of active caspase-3 were done in muscle sections. The donor cell labels disappeared from the muscles following donor cell death, but this was not instantaneous and even if the donor cells were killed before transplantation, the first 6 hours were not enough to clear [14C]thymidine and Y chromosome. Using the cell pellet before injection as the 100% baseline for cells injected to evaluate cell death can lead to misinterpretations: the Y-chromosome band was 5-fold stronger than that of a muscle injected with cells, irrespective of whether the cells were previously killed or not. There was no evidence of an immediate massive donor cell death. Necrosis (detected by alizarin red) and apoptosis (detected by active caspase-3) were present among the donor myoblasts following transplantation. Necrosis seemed to be the most important mechanism during the first hours. T-antigen immortalized cells died earlier and more massively than primary-cultured cells, but the surviving cells proliferated more. Indeed, they seemed to exhibit more apoptosis and they triggered a more rapid CD8+ cell infiltration. As a result of our findings, many concepts concerning the early donor cell death following myoblast transplantation must be reconsidered.

Entities:  

Mesh:

Year:  2003        PMID: 14533784     DOI: 10.1093/jnen/62.9.951

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  32 in total

1.  Slowing down differentiation of engrafted human myoblasts into immunodeficient mice correlates with increased proliferation and migration.

Authors:  Ingo Riederer; Elisa Negroni; Maximilien Bencze; Annie Wolff; Ahmed Aamiri; James P Di Santo; Suse D Silva-Barbosa; Gillian Butler-Browne; Wilson Savino; Vincent Mouly
Journal:  Mol Ther       Date:  2011-09-20       Impact factor: 11.454

2.  Active scaffolds for on-demand drug and cell delivery.

Authors:  Xuanhe Zhao; Jaeyun Kim; Christine A Cezar; Nathaniel Huebsch; Kangwon Lee; Kamal Bouhadir; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-13       Impact factor: 11.205

3.  Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging.

Authors:  Manickam Krishnan; Jinha M Park; Feng Cao; Dongxu Wang; Ramasay Paulmurugan; Jeffrey R Tseng; Mark L Gonzalgo; Sanjiv S Gambhir; Joseph C Wu
Journal:  FASEB J       Date:  2005-10-24       Impact factor: 5.191

4.  The survival of engrafted neural stem cells within hyaluronic acid hydrogels.

Authors:  Yajie Liang; Piotr Walczak; Jeff W M Bulte
Journal:  Biomaterials       Date:  2013-04-25       Impact factor: 12.479

5.  Clarifying misconceptions about myoblast transplantation in myology.

Authors:  Daniel Skuk; Jacques P Tremblay
Journal:  Mol Ther       Date:  2014-05       Impact factor: 11.454

6.  Obestatin Increases the Regenerative Capacity of Human Myoblasts Transplanted Intramuscularly in an Immunodeficient Mouse Model.

Authors:  Icia Santos-Zas; Elisa Negroni; Kamel Mamchaoui; Carlos S Mosteiro; Rosalia Gallego; Gillian S Butler-Browne; Yolanda Pazos; Vincent Mouly; Jesus P Camiña
Journal:  Mol Ther       Date:  2017-07-24       Impact factor: 11.454

7.  The muscle regulatory transcription factor MyoD participates with p53 to directly increase the expression of the pro-apoptotic Bcl2 family member PUMA.

Authors:  Terri J Harford; Greg Kliment; Girish C Shukla; Crystal M Weyman
Journal:  Apoptosis       Date:  2017-12       Impact factor: 4.677

8.  Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts.

Authors:  Narutoshi Hibino; Daniel R Duncan; Ani Nalbandian; Tai Yi; Yibing Qyang; Toshiharu Shinoka; Christopher K Breuer
Journal:  J Thorac Cardiovasc Surg       Date:  2012-01-12       Impact factor: 5.209

9.  Prostaglandin F2alpha promotes muscle cell survival and growth through upregulation of the inhibitor of apoptosis protein BRUCE.

Authors:  K M Jansen; G K Pavlath
Journal:  Cell Death Differ       Date:  2008-06-20       Impact factor: 15.828

Review 10.  Stem cells for skeletal muscle regeneration: therapeutic potential and roadblocks.

Authors:  Fabrizio Rinaldi; Rita C R Perlingeiro
Journal:  Transl Res       Date:  2013-11-14       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.